One of the Autoimmune Registry's goals is to increase awareness of autoimmune diseases to improve existing treatment protocols and disease management strategies. Clinical trials are a crucial part of testing new treatments and participation is important to ensure that new medications are approved for the public.

Although there are various treatment options for autoimmune disease, researchers are always looking to develop the next best treatment. Scientists at Mayo Clinic have developed an innovative immunotherapy approach that could revolutionize autoimmune disease treatment.

Once thought to be a rare disease, Sjogren's is now recognized as one of the most prevalent autoimmune diseases, affecting an estimated 1 to 4 million people in the United States.

Autoimmune diseases are notorious for their lengthy diagnostic process. Patients often suffer for years without a diagnosis or are misdiagnosed, leading to delays in proper treatment.

New research on rheumatoid arthritis (RA) has focused on the early stages of the disease when intervention may help prevent or mitigate the disease.

Lichen Sclerosus (LS) is a chronic inflammatory skin condition that causes patches of skin to look white, thickened, and crinkly around the genital and anal areas. While this condition can occur in both men and women, it is more commonly diagnosed in women.

Although March is Autoimmune Awareness Month, it is also Women's History Month. It is no surprise that these two celebrations coincide, especially since autoimmune diseases stand out as a significant and often overlooked aspect of women's health.

Every day, millions of autoimmune disease patients suffer in silence with what are often "invisible" illnesses. With March set as Autoimmune Disease Awareness Month, this is our time to advocate for our diseases and show the world who we are!

The National Institutes of Health defines a rare disease as one that affects fewer than 200,000 persons in the US. But is every rare disease truly rare?

World Encephalitis Day occurs every February 22nd to raise global awareness for those who have been affected by encephalitis, a condition characterized by inflammation of the brain.

In honor of Black History Month, the Autoimmune Registry is focusing on the intersections between health and identity.

Autoimmune diseases pose a significant health challenge and it is estimated that you or someone you know will develop an autoimmune disease at some point.

Autoimmune diseases are known for disproportionately affecting women, with 70-80% of those diagnosed being women. Recently, a study led by Stanford University sheds light on why autoimmune diseases are more prevalent in women than in men through a molecule called Xist (pronounced as "exist").

Receiving an autoimmune disease diagnosis can be life-altering since it leads individuals into a challenging journey of managing their symptoms, receiving treatments, and experiencing the emotional toll of living with a chronic condition.

Autoimmune diseases have long been under the limelight as a class of diseases. While cancer and heart disease statistics are often aggregated to show their impact, autoimmune diseases are rarely classified as a class.

Autoimmune diseases can manifest in various ways, and some symptoms can go unnoticed or be attributed to other causes. Some common autoimmune disease symptoms are fatigue, joint pain and swelling, skin problems, recurring fever, and more.

It's been four years since the beginning of the pandemic and the medical community continues to struggle with the complexities of the lingering effects of COVID-19, also known as Long-COVID.

As we embark on a new year, many individuals are forming goals and habits that benefit their health and well-being, such as exercising, meditating, or eating healthier foods. Those with chronic illnesses may also have the goal of managing their symptoms.

Back in June, we discussed how CAR-T therapy may be used to treat various autoimmune diseases such as lupus and myasthenia gravis. Although CAR-T therapy is mainly used to fight cancer, researchers have been able to use this therapy to modify T-cells to attack B-cells that incorrectly produce antibodies that attack their own cells.

As 2023 draws to a close, we want to give everyone a recap of the past year. To raise awareness of autoimmune diseases, we wrote a blog post on autoinflammatory diseases for Global Genes and continued to expand our network by connecting with individual disease advocacy groups.